Hepatitis viruses and non-Hodgkin lymphoma: Epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities

Fabrizio Marcucci, Alfonso Mele

Research output: Contribution to journalArticle

Abstract

Over the past 2 decades considerable evidence has accumulated on the association between hepatitis C virus (HCV) and hepatitis B virus (HBV) and several hematologic malignancies, most notably B-cell non-Hodgkin lymphoma (NHL). In this review we summarize this evidence, address possible mechanisms whereby hepatitis viruses may contribute to lymphomagenesis, and discuss the therapeutic fallouts from this knowledge. Most of this evidence is on HCV, and this is the main focus of the review. Moreover, we mainly address the association with NHL, the most prevalent hematologic malignancy, and the most extensively investigated with regard to an association with hepatitis viruses. Available evidence on the association with other hematologic malignancies is also addressed briefly.

Original languageEnglish
Pages (from-to)1792-1798
Number of pages7
JournalBlood
Volume117
Issue number6
DOIs
Publication statusPublished - Feb 10 2011

Fingerprint

Hepatitis Viruses
Epidemiology
Hematologic Neoplasms
Viruses
Non-Hodgkin's Lymphoma
Carcinogenesis
Hepacivirus
B-Cell Lymphoma
Hepatitis B virus
Therapeutics
Cells

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Hepatitis viruses and non-Hodgkin lymphoma : Epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. / Marcucci, Fabrizio; Mele, Alfonso.

In: Blood, Vol. 117, No. 6, 10.02.2011, p. 1792-1798.

Research output: Contribution to journalArticle

Marcucci, Fabrizio ; Mele, Alfonso. / Hepatitis viruses and non-Hodgkin lymphoma : Epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. In: Blood. 2011 ; Vol. 117, No. 6. pp. 1792-1798.
@article{1db0bacdd6eb40f286c3342d03402212,
title = "Hepatitis viruses and non-Hodgkin lymphoma: Epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities",
abstract = "Over the past 2 decades considerable evidence has accumulated on the association between hepatitis C virus (HCV) and hepatitis B virus (HBV) and several hematologic malignancies, most notably B-cell non-Hodgkin lymphoma (NHL). In this review we summarize this evidence, address possible mechanisms whereby hepatitis viruses may contribute to lymphomagenesis, and discuss the therapeutic fallouts from this knowledge. Most of this evidence is on HCV, and this is the main focus of the review. Moreover, we mainly address the association with NHL, the most prevalent hematologic malignancy, and the most extensively investigated with regard to an association with hepatitis viruses. Available evidence on the association with other hematologic malignancies is also addressed briefly.",
author = "Fabrizio Marcucci and Alfonso Mele",
year = "2011",
month = "2",
day = "10",
doi = "10.1182/blood-2010-06-275818",
language = "English",
volume = "117",
pages = "1792--1798",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

TY - JOUR

T1 - Hepatitis viruses and non-Hodgkin lymphoma

T2 - Epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities

AU - Marcucci, Fabrizio

AU - Mele, Alfonso

PY - 2011/2/10

Y1 - 2011/2/10

N2 - Over the past 2 decades considerable evidence has accumulated on the association between hepatitis C virus (HCV) and hepatitis B virus (HBV) and several hematologic malignancies, most notably B-cell non-Hodgkin lymphoma (NHL). In this review we summarize this evidence, address possible mechanisms whereby hepatitis viruses may contribute to lymphomagenesis, and discuss the therapeutic fallouts from this knowledge. Most of this evidence is on HCV, and this is the main focus of the review. Moreover, we mainly address the association with NHL, the most prevalent hematologic malignancy, and the most extensively investigated with regard to an association with hepatitis viruses. Available evidence on the association with other hematologic malignancies is also addressed briefly.

AB - Over the past 2 decades considerable evidence has accumulated on the association between hepatitis C virus (HCV) and hepatitis B virus (HBV) and several hematologic malignancies, most notably B-cell non-Hodgkin lymphoma (NHL). In this review we summarize this evidence, address possible mechanisms whereby hepatitis viruses may contribute to lymphomagenesis, and discuss the therapeutic fallouts from this knowledge. Most of this evidence is on HCV, and this is the main focus of the review. Moreover, we mainly address the association with NHL, the most prevalent hematologic malignancy, and the most extensively investigated with regard to an association with hepatitis viruses. Available evidence on the association with other hematologic malignancies is also addressed briefly.

UR - http://www.scopus.com/inward/record.url?scp=79951468929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951468929&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-06-275818

DO - 10.1182/blood-2010-06-275818

M3 - Article

C2 - 20959600

AN - SCOPUS:79951468929

VL - 117

SP - 1792

EP - 1798

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -